致死因子抗体有助于炭疽疫苗沉淀接种者的致死毒素中和
研究比较了英国炭疽疫苗沉淀(AVP,n=39)与美国炭疽疫苗吸附(AVA,n=78)接种者的体液免疫应答,两组按接种次数和接种后时间1:2匹配;AVP组致死毒素中和ED50更高且致死因子IgG阳性率更高,致死因子IgG对致死毒素中和有独立且叠加的贡献。
要点
- AVP组致死毒素中和ED50为1464.0±214.7,高于AVA组的544.9±83.2(p<0.0001)。
- AVP组致死因子IgG阳性率为95%,匹配的AVA接种者为1%。
- 多元回归分析显示致死因子IgG对AVP组的致死毒素中和应答有独立且叠加的贡献。
核心结论
- 本研究记录了在基于保护性抗原的炭疽疫苗中加入致死因子组分的益处。
研究设计与样本
- 比较AVP接种者(n=39)与AVA接种者(n=78)的体液免疫应答,两组按接种次数和接种后时间1:2匹配。
主要发现
- 两组保护性抗原应答率(≥95%)和PA IgG浓度相似。
- AVP组致死毒素中和ED50为1464.0±214.7,AVA组为544.9±83.2(p<0.0001)。
- AVP组致死因子IgG阳性率为95%,匹配的AVA接种者为1%。
- 多元回归分析显示致死因子IgG对AVP组的致死毒素中和应答有独立且叠加的贡献。
- 从两名独立AVP接种者亲和纯化的致死因子抗体能中和致死毒素并结合致死因子结构域1。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A major difference between two currently licensed anthrax vaccines is presence (United Kingdom Anthrax Vaccine Precipitated, AVP) or absence (United States Anthrax Vaccine Adsorbed, AVA) of quantifiable amounts of the Lethal Toxin (LT) component Lethal Factor (LF). The primary immunogen in both vaccine formulations is Protective Antigen (PA), and LT-neutralizing antibodies directed to PA are an accepted correlate of vaccine efficacy; however, vaccination studies in animal models have demonstrated that LF antibodies can be protective. In this report we compared humoral immune responses in cohorts of AVP (n=39) and AVA recipients (n=78) matched 1:2 for number of vaccinations and time post-vaccination, and evaluated whether the LF response contributes to LT neutralization in human recipients of AVP. PA response rates (≥95%) and PA IgG concentrations were similar in both groups; however, AVP recipients exhibited higher LT neutralization ED50 values (AVP: 1464.0±214.7, AVA: 544.9±83.2, p<0.0001) and had higher rates of LF IgG positivity (95%) compared to matched AVA vaccinees (1%). Multiple regression analysis revealed that LF IgG makes an independent and additive contribution to the LT neutralization response in the AVP group. Affinity purified LF antibodies from two independent AVP recipients neutralized LT and bound to LF Domain 1, confirming contribution of LF antibodies to LT neutralization. This study documents the benefit of including an LF component to PA-based anthrax vaccines.
引用
- Dumas EK, Garman L, Cuthbertson H, et al. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated. Vaccine. 2017. PMID: 28504191. doi:10.1016/j.vaccine.2017.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。